MedCity News October 13, 2020
Elise Reuter

Medicare doesn’t currently cover drugs approved under emergency use designations. But CMS Administrator Seema Verma said the agency was coming up with a plan to make sure Medicare beneficiaries were covered once a coronavirus vaccine is developed.

Most of the nation’s attention is currently focused on the development and approval of a coronavirus vaccine. But there are still many hurdles to getting a working vaccine to patients — from the logistics of transporting a vaccine that might need to be refrigerated, to having enough glass vials to contain it. And for some, there’s the lingering question: Will it be covered?

U.S. officials have said they expect private insurers to cover the cost of a vaccine with no co-pay for patients....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, Healthcare System, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health / COVID
The Ripple Effect: Ways to Make Health in All Policies Stick in Kansas and Beyond to Enhance Health and Equity
Research Funding Is Needed To Support An Effective, Equitable, And Sustainable Public Health System
Covid’s scientific silver lining: A chance to watch the human immune system respond in real time
New Data: Long COVID Cases Surge
New federal health IT strategy increases focus on public health, AI

Share This Article